3D Global Biotech Inc.
6808
Rank in Stocks
#21906
Based in New Taipei City, China, 3D Global Biotech Inc. (3DGBI) specializes in... Based in New Taipei City, China, 3D Global Biotech Inc. (3DGBI) specializes in the development of advanced medical materials designed for human body reconstruction. The company leverages sophisticated cell culture systems, cutting-edge 3D printing technology, and proprietary bio-inks hydrogel to create personalized, patient-specific cell-based medical products. Beyond product manufacturing, 3DGBI is dedicated to building platforms for human tissue and organ regeneration, engineering customized medical equipment, and undertaking significant professional research. Its extensive product range includes artificial bone substitutes, skull fixation systems, biological dressings, bio-inks, and bioprinting machinery. They also offer specialized solutions for orthopedic, dental, cranial, and scalp reconstruction. The company serves a broad spectrum of clients, including medical centers, research institutions, businesses, and distributors. 3DGBI actively fosters an interdisciplinary alliance, bringing together expertise from industry, government, academia, research, and medicine. It was established in 2014.
Share Price
$0.79259593
Last synced: 2026-11-10
Market Cap
$61.02M
Change (1 day)
0.00%
Change (1 year)
-47.06%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade 3D Global Biotech Inc. (6808)
Category
Healthcare
Operating Margin for 3D Global Biotech Inc. (6808)
Operating Margin as of November 2026 TTM: -3.86%
According to 3D Global Biotech Inc.'s latest financial reports, its current operating margin (TTM) is -3.86%. At the end of 2025 the company had an operating margin of 20.05%.
Operating Margin history for 3D Global Biotech Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -3.86% | -119.25% |
| 2025 | 20.05% | -39.95% |
| 2024 | 33.39% | -110.96% |
| 2023 | -304.62% | -37.30% |
| 2022 | -485.87% | -13.50% |
| 2021 | -561.71% | 48.01% |
| 2020 | -379.52% | 90.02% |
| 2019 | -199.73% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -110.00% |
US
|
|
| -149.01% | -61.40% |
US
|
|
| 25.57% | -106.62% |
AU
|
|
| 31.23% | -108.09% |
BE
|
|
| 29.35% | -107.60% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about 3D Global Biotech Inc.'s operating margin
What is 3D Global Biotech Inc.'s operating margin?
3D Global Biotech Inc.'s operating margin is -3.86%, as of Nov 2026.
What was 3D Global Biotech Inc.'s operating margin in 2025?
In 2025, 3D Global Biotech Inc.'s operating margin was 20.05%, compared with 33.39% in 2024.
How has 3D Global Biotech Inc.'s operating margin changed since 2020?
From 2020 to 2025, 3D Global Biotech Inc.'s operating margin was highest in 2024 (33.39%) and lowest in 2021 (-561.71%).
How does 3D Global Biotech Inc.'s operating margin compare with similar companies?
3D Global Biotech Inc.'s operating margin (-3.86%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.